Cara Therapeutics Ownership 2024 | Who Owns Cara Therapeutics Now?
Institutional Ownership
40.04%
Insider Ownership
15.25%
Retail Ownership
44.70%
Institutional Holders
92.00
Cara Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 6.32% | 0.00% | 3,421,363 | -132,895 | -3.74% | 3,113,440 | Mar 31, 2024 |
| VANGUARD GROUP INC | 4.58% | - | 2,481,258 | -149,809 | -5.69% | 2,257,944 | Mar 31, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 3.35% | 0.03% | 1,815,058 | 2,958 | 0.16% | 1,651,703 | Mar 31, 2024 |
| CHESCAPMANAGER LLC | 3.14% | 0.15% | 1,702,110 | -50,002 | -2.85% | 1,548,920 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 2.87% | 0.01% | 1,556,251 | - | - | 1,416,188 | Mar 31, 2024 |
| ROSALIND ADVISORS, INC. | 2.86% | 1.32% | 1,548,893 | 1,548,893 | 100.00% | 1,409,493 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.46% | 0.00% | 1,332,478 | 635,448 | 91.17% | 1,213,000 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.89% | 0.00% | 1,021,599 | 12,640 | 1.25% | 929,765 | Mar 31, 2024 |
| STATE STREET CORP | 1.85% | - | 1,002,954 | -17,924 | -1.76% | 912,688 | Mar 31, 2024 |
| STIFEL FINANCIAL CORP | 1.37% | 0.00% | 741,374 | 428,316 | 136.82% | 674,650 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.22% | 0.00% | 661,834 | 194,647 | 41.66% | 602,269 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 1.22% | 0.00% | 659,900 | 145,700 | 28.34% | 600,509 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.18% | 0.00% | 636,230 | -8,587 | -1.33% | 578,969,000 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.95% | 0.24% | 512,213 | 512,213 | 100.00% | 466,114 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.72% | 0.00% | 390,807 | -1,005 | -0.26% | 355,634 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.72% | 0.00% | 390,602 | -159,427 | -28.99% | 355,448 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.62% | 0.00% | 334,231 | -26,242 | -7.28% | 303,000 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.61% | 0.00% | 328,791 | 60,173 | 22.40% | 299,200 | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.53% | 0.00% | 286,205 | -6,649 | -2.27% | 260,447 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.51% | 0.00% | 277,978 | -29,293 | -9.53% | 252,960 | Mar 31, 2024 |
Cara Therapeutics's largest institutional shareholder is BLACKROCK INC., holding 6.32% of the company's total share outstanding, currently valued at $3.11M. The top 10 institutional shareholders own together 30.70% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 2.86% | 1.32% | 1,548,893 | 1,548,893 | 100.00% | 1,409,493 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.95% | 0.24% | 512,213 | 512,213 | 100.00% | 466,114 | Mar 31, 2024 |
| CHESCAPMANAGER LLC | 3.14% | 0.15% | 1,702,110 | -50,002 | -2.85% | 1,548,920 | Mar 31, 2024 |
| DISCIPLINED GROWTH INVESTORS INC /MN | 3.35% | 0.03% | 1,815,058 | 2,958 | 0.16% | 1,651,703 | Mar 31, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.17% | 0.01% | 94,238 | 94,238 | 100.00% | 85,757 | Mar 31, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 2.87% | 0.01% | 1,556,251 | - | - | 1,416,188 | Mar 31, 2024 |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 0.01% | 0.00% | 5,000 | -350 | -6.54% | 4,550 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.07% | 0.00% | 36,236 | 9,012 | 33.10% | 32,975 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.08% | 0.00% | 45,268 | -179,894 | -79.90% | 41,000 | Mar 31, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.05% | 0.00% | 25,403 | 25,403 | 100.00% | 23,117 | Mar 31, 2024 |
| B. RILEY WEALTH ADVISORS, INC. | 0.10% | 0.00% | 55,648 | -6,010 | -9.75% | 93,489 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.72% | 0.00% | 390,602 | -159,427 | -28.99% | 355,448 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.46% | 0.00% | 1,332,478 | 635,448 | 91.17% | 1,213,000 | Mar 31, 2024 |
| JAG CAPITAL MANAGEMENT, LLC | 0.02% | 0.00% | 11,235 | - | - | 10,224 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 1.22% | 0.00% | 659,900 | 145,700 | 28.34% | 600,509 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.62% | 0.00% | 334,231 | -26,242 | -7.28% | 303,000 | Mar 31, 2024 |
| STIFEL FINANCIAL CORP | 1.37% | 0.00% | 741,374 | 428,316 | 136.82% | 674,650 | Mar 31, 2024 |
| PENSERRA CAPITAL MANAGEMENT LLC | 0.12% | 0.00% | 65,538 | -16,004 | -19.63% | 59,000 | Mar 31, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.01% | 0.00% | 7,275 | - | - | 6,621,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.51% | 0.00% | 277,978 | -29,293 | -9.53% | 252,960 | Mar 31, 2024 |
The largest Cara Therapeutics shareholder by % of total assets is ROSALIND ADVISORS, INC.. The company owns 1.55M shares of Cara Therapeutics (CARA), representing 1.32% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 2.86% | 1.32% | 1,548,893 | 1,548,893 | 100.00% | 1,409,493 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 2.46% | 0.00% | 1,332,478 | 635,448 | 91.17% | 1,213,000 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.95% | 0.24% | 512,213 | 512,213 | 100.00% | 466,114 | Mar 31, 2024 |
| STIFEL FINANCIAL CORP | 1.37% | 0.00% | 741,374 | 428,316 | 136.82% | 674,650 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 1.22% | 0.00% | 661,834 | 194,647 | 41.66% | 602,269 | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | 1.22% | 0.00% | 659,900 | 145,700 | 28.34% | 600,509 | Mar 31, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.17% | 0.01% | 94,238 | 94,238 | 100.00% | 85,757 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.11% | - | 61,815 | 61,815 | 100.00% | 56,252 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.61% | 0.00% | 328,791 | 60,173 | 22.40% | 299,200 | Mar 31, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.37% | 0.00% | 201,871 | 56,979 | 39.33% | 183,703 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.09% | 0.00% | 50,000 | 50,000 | 100.00% | 45,500 | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.07% | - | 35,791 | 35,791 | 100.00% | 32,570 | Mar 31, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.05% | 0.00% | 25,403 | 25,403 | 100.00% | 23,117 | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.04% | 0.00% | 21,214 | 21,214 | 100.00% | 104,797 | Mar 31, 2024 |
| UBS GROUP AG | 0.10% | - | 51,432 | 14,983 | 41.11% | 46,803 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.89% | 0.00% | 1,021,599 | 12,640 | 1.25% | 929,765 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 12,308 | 12,308 | 100.00% | 11,000 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.07% | 0.00% | 36,236 | 9,012 | 33.10% | 32,975 | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.03% | 0.00% | 18,545 | 6,394 | 52.62% | 91,056 | Mar 31, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.32% | 0.00% | 173,331 | 5,493 | 3.27% | 157,731 | Mar 31, 2024 |
As of Mar 31 2024, Cara Therapeutics's largest institutional buyer is ROSALIND ADVISORS, INC.. The company purchased 1.55M stocks of CARA, valued at $1.41M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 0.02% | - | 12,272 | -819,577 | -98.52% | 11,168 | Mar 31, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.05% | - | 28,818 | -799,981 | -96.52% | 26,224 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -696,868 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | 0.20% | - | 105,863 | -187,285 | -63.89% | 96,335 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.08% | 0.00% | 45,268 | -179,894 | -79.90% | 41,000 | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -167,314 | -100.00% | - | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.72% | 0.00% | 390,602 | -159,427 | -28.99% | 355,448 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.10% | - | 51,643 | -158,229 | -75.39% | 46,995 | Mar 31, 2024 |
| VANGUARD GROUP INC | 4.58% | - | 2,481,258 | -149,809 | -5.69% | 2,257,944 | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -141,200 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | 6.32% | 0.00% | 3,421,363 | -132,895 | -3.74% | 3,113,440 | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -117,471 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -93,385 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -85,742 | -100.00% | - | Mar 31, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -81,590 | -100.00% | - | Mar 31, 2024 |
| SG AMERICAS SECURITIES, LLC | 0.03% | 0.00% | 15,992 | -56,120 | -77.82% | 15,000 | Mar 31, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | - | - | - | -54,955 | -100.00% | - | Mar 31, 2024 |
| CHESCAPMANAGER LLC | 3.14% | 0.15% | 1,702,110 | -50,002 | -2.85% | 1,548,920 | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -38,586 | -100.00% | - | Mar 31, 2024 |
| MACKENZIE FINANCIAL CORP | 0.04% | - | 21,176 | -32,502 | -60.55% | 19,270 | Mar 31, 2024 |
As of Mar 31 2024, Cara Therapeutics's biggest institutional seller is FEDERATED HERMES, INC.. The company sold -0.82M shares of CARA, valued at $11.17K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ROSALIND ADVISORS, INC. | 2.86% | 1.32% | 1,548,893 | 1,548,893 | 100.00% | 1,409,493 | Mar 31, 2024 |
| ACUITAS INVESTMENTS, LLC | 0.95% | 0.24% | 512,213 | 512,213 | 100.00% | 466,114 | Mar 31, 2024 |
| MARQUETTE ASSET MANAGEMENT, LLC | 0.17% | 0.01% | 94,238 | 94,238 | 100.00% | 85,757 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.11% | - | 61,815 | 61,815 | 100.00% | 56,252 | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.09% | 0.00% | 50,000 | 50,000 | 100.00% | 45,500 | Mar 31, 2024 |
| ENVESTNET ASSET MANAGEMENT INC | 0.07% | - | 35,791 | 35,791 | 100.00% | 32,570 | Mar 31, 2024 |
| FIDELIS CAPITAL PARTNERS, LLC | 0.05% | 0.00% | 25,403 | 25,403 | 100.00% | 23,117 | Mar 31, 2024 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 0.04% | 0.00% | 21,214 | 21,214 | 100.00% | 104,797 | Mar 31, 2024 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.02% | - | 12,308 | 12,308 | 100.00% | 11,000 | Mar 31, 2024 |
| 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 1,501 | Mar 31, 2024 | |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 0.00% | 0.00% | 634 | 634 | 100.00% | 577,000 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 10 | 10 | 100.00% | 9 | Mar 31, 2024 |
Cara Therapeutics's largest new institutional shareholder by number of shares is ROSALIND ADVISORS, INC., purchased 1.55M shares, valued at $1.41M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -696,868 | -100.00% | - | Mar 31, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -167,314 | -100.00% | - | Mar 31, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | - | - | - | -141,200 | -100.00% | - | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -117,471 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -93,385 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -85,742 | -100.00% | - | Mar 31, 2024 |
| MML INVESTORS SERVICES, LLC | - | - | - | -81,590 | -100.00% | - | Mar 31, 2024 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | - | - | - | -54,955 | -100.00% | - | Mar 31, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -38,586 | -100.00% | - | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -31,536 | -100.00% | - | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -30,740 | -100.00% | - | Mar 31, 2024 |
| STATE OF WYOMING | - | - | - | -27,690 | -100.00% | - | Mar 31, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -25,000 | -100.00% | - | Mar 31, 2024 |
| SCIENTECH RESEARCH LLC | - | - | - | -21,910 | -100.00% | - | Mar 31, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | - | - | - | -17,376 | -100.00% | - | Mar 31, 2024 |
| WEXFORD CAPITAL LP | - | - | - | -17,090 | -100.00% | - | Mar 31, 2024 |
| PATHSTONE HOLDINGS, LLC | - | - | - | -12,331 | -100.00% | - | Mar 31, 2024 |
| PINNACLE ASSOCIATES LTD | - | - | - | -11,727 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -10,930 | -100.00% | - | Mar 31, 2024 |
| INTREPID FINANCIAL PLANNING GROUP LLC | - | - | - | -10,500 | -100.00% | - | Mar 31, 2024 |
| LGT FINANCIAL ADVISORS LLC | - | - | - | -183 | -100.00% | - | Mar 31, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -70 | -100.00% | - | Mar 31, 2024 |
| VERSANT CAPITAL MANAGEMENT, INC | - | - | - | -55 | -100.00% | - | Mar 31, 2024 |
Cara Therapeutics's largest sold out institutional shareholder by shares sold is JACOBS LEVY EQUITY MANAGEMENT, INC, sold -0.70M shares, valued at -, as of undefined.
Cara Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Federated Hermes MDT Series | 0.32% | 800,390 | 41,434 | 5.46% | Jan 31, 2024 |
| ROYCE VALUE TRUST, INC. | 0.17% | 202,300 | - | - | Dec 31, 2023 |
| SYNTAX ETF TRUST | 0.10% | 3,297 | - | - | Dec 31, 2023 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.10% | 377,827 | - | - | Dec 31, 2023 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.08% | 383,715 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 33,414 | - | - | Dec 31, 2023 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.07% | 497,110 | - | - | Dec 31, 2023 |
| BNY MELLON INDEX FUNDS, INC. | 0.06% | 64,940 | - | - | Jan 31, 2024 |
| VANGUARD ADMIRAL FUNDS | 0.06% | 252,040 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.06% | 141,200 | - | - | Dec 29, 2023 |
| ETF Managers Trust | 0.06% | 434,527 | - | - | Dec 31, 2023 |
| PFM Multi-Manager Series Trust | 0.05% | 37,699 | - | - | Dec 31, 2023 |
| BNY MELLON INVESTMENT PORTFOLIOS | 0.05% | 26,631 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.03% | 478,119 | - | - | Dec 31, 2023 |
| Spinnaker ETF Series | 0.03% | 19,346 | - | - | Dec 31, 2023 |
| AdvisorShares Trust | 0.03% | 85,121 | - | - | Dec 29, 2023 |
| IndexIQ ETF Trust | 0.02% | 47,169 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 8,323 | - | - | Dec 31, 2023 |
| AMG FUNDS III | 0.02% | 2,987 | - | - | Feb 29, 2024 |
| Humankind Benefit Corp | 0.02% | 390 | - | - | Dec 31, 2023 |
| VANGUARD HORIZON FUNDS | 0.02% | 345,530 | 172,765 | 100.00% | Dec 31, 2023 |
| Fidelity Commonwealth Trust II | 0.01% | 95,825 | 58,437 | 156.30% | Aug 31, 2023 |
| T. Rowe Price Equity Funds, Inc. | 0.01% | 239,548 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 77,774 | - | - | Dec 31, 2023 |
| PUTNAM ASSET ALLOCATION FUNDS | 0.01% | 23,178 | - | - | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 17,336 | - | - | Dec 31, 2023 |
| Guardian Variable Products Trust | 0.01% | 165,600 | - | - | Dec 31, 2023 |
| EXCHANGE TRADED CONCEPTS TRUST | 0.01% | 46,822 | - | - | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.01% | 95,816 | -9 | -0.01% | Feb 29, 2024 |
| ETFis Series Trust I | 0.01% | 8,659 | - | - | Jan 31, 2024 |
| Amplify ETF Trust | 0.01% | 65,538 | -16,004 | -19.63% | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,645,819 | 645,753 | 32.29% | Dec 31, 2023 |
| JNL VARIABLE FUND LLC | 0.01% | 29,125 | - | - | Mar 31, 2020 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.00% | 18,160 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 144,892 | 65,911 | 83.45% | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 1,052 | - | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 56,907 | -1,272 | -2.19% | Dec 31, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 106,260 | - | - | Dec 31, 2023 |
| ALPS ETF Trust | 0.00% | 35,791 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 436,160 | 44,185 | 11.27% | Feb 29, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 15,900 | - | - | Dec 29, 2023 |
| Advisors' Inner Circle Fund III | 0.00% | 24,153 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,311 | - | - | Dec 31, 2023 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 17,506 | - | - | Feb 29, 2024 |
| STEWARD FUNDS, INC. | 0.00% | 2,880 | - | - | Jan 31, 2024 |
| VANGUARD TAX-MANAGED FUNDS | 0.00% | 396,991 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 33,488 | - | - | Dec 31, 2023 |
| PRAXIS MUTUAL FUNDS | 0.00% | 11,140 | - | - | Dec 31, 2023 |
| TIMOTHY PLAN | 0.00% | 4,381 | - | - | Mar 31, 2024 |
| Mutual of America Variable Insurance Portfolios, Inc. | 0.00% | 690 | - | - | Sep 30, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 166,824 | -93,291 | -35.87% | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 274,682 | - | - | Jan 31, 2024 |
| SHELTON FUNDS | 0.00% | 1,387 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 9,986 | -1,539 | -13.35% | Mar 31, 2024 |
| AMG Funds I | 0.00% | 1,234 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 112,955 | -3,229 | -2.78% | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 167,355 | 26,386 | 18.72% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 2,942 | - | - | Dec 31, 2023 |
| SunAmerica Specialty Series | 0.00% | 339 | - | - | Apr 30, 2021 |
| MML SERIES INVESTMENT FUND | 0.00% | 5,497 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,213 | - | - | Dec 31, 2023 |
| PRUDENTIAL SERIES FUND | 0.00% | 39,613 | - | - | Dec 29, 2023 |
| MUTUAL OF AMERICA INVESTMENT CORP | 0.00% | 17,900 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 8,301 | - | - | Dec 31, 2023 |
| THRIVENT SERIES FUND INC | 0.00% | 44,731 | - | - | Dec 29, 2023 |
| JPMORGAN INSURANCE TRUST | 0.00% | 4,888 | -212 | -4.16% | Mar 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 11,197 | - | - | Dec 31, 2023 |
| Guggenheim Variable Funds Trust | 0.00% | 1,478 | - | - | Dec 31, 2023 |
| Virtus Strategy Trust | 0.00% | 8,001 | - | - | Dec 29, 2023 |
| GPS Funds I | 0.00% | 1,791 | - | - | Dec 31, 2023 |
| VIRTUS ASSET TRUST | 0.00% | 9,092 | - | - | Dec 29, 2023 |
| Federated Hermes Global Allocation Fund | 0.00% | 3,212 | - | - | Feb 29, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 4,179 | - | - | Jan 31, 2024 |
| Trust for Advised Portfolios | 0.00% | 5,311 | - | - | Dec 31, 2023 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,972 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 679 | - | - | Dec 31, 2023 |
| Nushares ETF Trust | 0.00% | 1,740 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 73,145 | - | - | Jan 31, 2024 |
| JPMORGAN TRUST II | 0.00% | 162,900 | - | - | Feb 29, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 19,375 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 176,319 | -7,040 | -3.84% | Dec 31, 2023 |
| Meeder Funds | 0.00% | 660 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 2,330 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,377 | - | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 11,300 | - | - | Dec 31, 2023 |
| Voya INVESTORS TRUST | 0.00% | 6,317 | - | - | Dec 31, 2023 |
| SEASONS SERIES TRUST | 0.00% | 2,856 | - | - | Dec 31, 2023 |
| Chartwell Funds | 0.00% | 2,517 | - | - | Jun 30, 2022 |
| iSHARES TRUST | 0.00% | 1,858,742 | - | - | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 6,064 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.00% | 427 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 202,891 | 22,144 | 12.25% | Feb 29, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 7,565 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 666 | 273 | 69.47% | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 30,787 | - | - | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 6,535 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 17,949 | -73 | -0.41% | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 7,300 | 5,500 | 305.56% | Dec 31, 2023 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 3,700 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 1,500 | - | - | Dec 29, 2023 |
Cara Therapeutics's largest mutual fund holder by % of total assets is "Federated Hermes MDT Series", owning 800.39K shares, compromising 0.32% of its total assets.
Cara Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 92 | -16.36% |
| 31 Dec, 23 | 110 | -11.29% |
| 30 Sep, 23 | 124 | -10.14% |
| 30 Jun, 23 | 138 | -15.85% |
| 31 Mar, 23 | 164 | -1.20% |
| 31 Dec, 22 | 166 | 4.40% |
| 30 Sep, 22 | 159 | -10.17% |
| 30 Jun, 22 | 177 | -5.35% |
| 31 Mar, 22 | 187 | -0.53% |
| 31 Dec, 21 | 188 | 6.82% |
| 30 Sep, 21 | 176 | -4.35% |
| 30 Jun, 21 | 184 | 1.10% |
| 31 Mar, 21 | 182 | 12.35% |
| 31 Dec, 20 | 162 | -1.22% |
| 30 Sep, 20 | 164 | 7.19% |
| 30 Jun, 20 | 153 | 9.29% |
| 31 Mar, 20 | 140 | -11.95% |
| 31 Dec, 19 | 159 | 8.90% |
| 30 Sep, 19 | 146 | 8.15% |
| 30 Jun, 19 | 135 | -8.78% |
| 31 Mar, 19 | 148 | 4.96% |
| 31 Dec, 18 | 141 | -10.76% |
| 30 Sep, 18 | 158 | 11.27% |
| 30 Jun, 18 | 142 | 14.52% |
| 31 Mar, 18 | 124 | -3.13% |
| 31 Dec, 17 | 128 | - |
| 30 Sep, 17 | 128 | -18.47% |
| 30 Jun, 17 | 157 | 19.85% |
| 31 Mar, 17 | 131 | 29.70% |
| 31 Dec, 16 | 101 | 20.24% |
| 30 Sep, 16 | 84 | 23.53% |
| 30 Jun, 16 | 68 | -26.09% |
| 31 Mar, 16 | 92 | -4.17% |
| 31 Dec, 15 | 96 | 6.67% |
| 30 Sep, 15 | 90 | 21.62% |
| 30 Jun, 15 | 74 | 25.42% |
| 31 Mar, 15 | 59 | 5.36% |
| 31 Dec, 14 | 56 | - |
| 30 Sep, 14 | 56 | 14.29% |
| 30 Jun, 14 | 49 | 16.67% |
| 31 Mar, 14 | 42 | - |
As of 31 Mar 24, 92 institutions are holding Cara Therapeutics's shares, representing a decrease of -16.36% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 21,683,438 | -10.74% |
| 31 Dec, 23 | 24,293,481 | -9.48% |
| 30 Sep, 23 | 26,837,228 | -7.87% |
| 30 Jun, 23 | 29,131,223 | -13.90% |
| 31 Mar, 23 | 33,835,514 | -0.34% |
| 31 Dec, 22 | 33,952,529 | -1.59% |
| 30 Sep, 22 | 34,502,710 | -0.68% |
| 30 Jun, 22 | 34,740,602 | 9.66% |
| 31 Mar, 22 | 31,678,911 | 5.52% |
| 31 Dec, 21 | 30,021,938 | 2.19% |
| 30 Sep, 21 | 29,378,845 | -5.28% |
| 30 Jun, 21 | 31,017,360 | -4.19% |
| 31 Mar, 21 | 32,375,292 | -0.73% |
| 31 Dec, 20 | 32,614,651 | -2.11% |
| 30 Sep, 20 | 33,319,028 | 1.87% |
| 30 Jun, 20 | 32,707,087 | 1.82% |
| 31 Mar, 20 | 32,121,301 | 2.87% |
| 31 Dec, 19 | 31,225,708 | 2.52% |
| 30 Sep, 19 | 30,457,856 | 18.84% |
| 30 Jun, 19 | 25,628,870 | 16.09% |
| 31 Mar, 19 | 22,077,470 | -7.87% |
| 31 Dec, 18 | 23,964,524 | 3.82% |
| 30 Sep, 18 | 23,082,854 | 21.84% |
| 30 Jun, 18 | 18,945,251 | 7.47% |
| 31 Mar, 18 | 17,627,964 | 4.30% |
| 31 Dec, 17 | 16,901,879 | -10.89% |
| 30 Sep, 17 | 18,967,192 | -4.79% |
| 30 Jun, 17 | 19,922,317 | 24.35% |
| 31 Mar, 17 | 16,020,762 | 16.74% |
| 31 Dec, 16 | 13,723,008 | 19.35% |
| 30 Sep, 16 | 11,498,368 | -13.57% |
| 30 Jun, 16 | 13,303,859 | -18.55% |
| 31 Mar, 16 | 16,333,717 | -19.10% |
| 31 Dec, 15 | 20,190,762 | 8.67% |
| 30 Sep, 15 | 18,579,702 | 54.59% |
| 30 Jun, 15 | 12,019,012 | 7.80% |
| 31 Mar, 15 | 11,149,420 | 7.00% |
| 31 Dec, 14 | 10,420,331 | 6.71% |
| 30 Sep, 14 | 9,764,866 | 10.98% |
| 30 Jun, 14 | 8,798,388 | 2.06% |
| 31 Mar, 14 | 8,621,122 | - |
Cara Therapeutics (CARA) has 21.68M shares outstanding as of 31 Mar 24, down -10.74% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 40.04% | 2.00% |
| 31 Dec, 23 | 44.79% | 1.81% |
| 30 Sep, 23 | 49.70% | 1.70% |
| 30 Jun, 23 | 54.07% | 1.37% |
| 31 Mar, 23 | 62.81% | 1.57% |
| 31 Dec, 22 | 63.15% | 1.53% |
| 30 Sep, 22 | 64.22% | 1.53% |
| 30 Jun, 22 | 64.80% | 1.85% |
| 31 Mar, 22 | 59.21% | 1.83% |
| 31 Dec, 21 | 56.91% | 1.66% |
| 30 Sep, 21 | 58.62% | 1.53% |
| 30 Jun, 21 | 61.96% | 1.47% |
| 31 Mar, 21 | 64.86% | 1.37% |
| 31 Dec, 20 | 68.79% | 1.36% |
| 30 Sep, 20 | 71.06% | 1.45% |
| 30 Jun, 20 | 69.89% | 1.48% |
| 31 Mar, 20 | 68.75% | 1.54% |
| 31 Dec, 19 | 66.88% | 1.43% |
| 30 Sep, 19 | 68.42% | 1.65% |
| 30 Jun, 19 | 64.36% | 2.07% |
| 31 Mar, 19 | 55.82% | 1.51% |
| 31 Dec, 18 | 60.76% | 1.65% |
| 30 Sep, 18 | 60.69% | 1.88% |
| 30 Jun, 18 | 56.87% | 1.95% |
| 31 Mar, 18 | 53.94% | 2.01% |
| 31 Dec, 17 | 51.79% | 1.53% |
| 30 Sep, 17 | 58.20% | 1.52% |
| 30 Jun, 17 | 61.79% | 1.79% |
| 31 Mar, 17 | 58.68% | 2.32% |
| 31 Dec, 16 | 50.31% | 2.83% |
| 30 Sep, 16 | 42.15% | 1.77% |
| 30 Jun, 16 | 48.76% | 1.36% |
| 31 Mar, 16 | 59.92% | 1.09% |
| 31 Dec, 15 | 74.12% | 1.40% |
| 30 Sep, 15 | 72.73% | 2.62% |
| 30 Jun, 15 | 52.65% | 2.20% |
| 31 Mar, 15 | 48.88% | 2.34% |
| 31 Dec, 14 | 45.72% | 2.47% |
| 30 Sep, 14 | 42.99% | 2.84% |
| 30 Jun, 14 | 38.92% | 1.28% |
| 31 Mar, 14 | 55.07% | - |
As of 31 Mar 24, Cara Therapeutics is held by 40.04% institutional shareholders, representing a 2.00% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 32 | -28.89% |
| 31 Dec, 23 | 45 | -13.46% |
| 30 Sep, 23 | 52 | -24.64% |
| 30 Jun, 23 | 69 | 2.99% |
| 31 Mar, 23 | 67 | -17.28% |
| 31 Dec, 22 | 81 | - |
| 30 Sep, 22 | 81 | 6.58% |
| 30 Jun, 22 | 76 | 2.70% |
| 31 Mar, 22 | 74 | -16.85% |
| 31 Dec, 21 | 89 | 18.67% |
| 30 Sep, 21 | 75 | -21.88% |
| 30 Jun, 21 | 96 | 18.52% |
| 31 Mar, 21 | 81 | 20.90% |
| 31 Dec, 20 | 67 | 3.08% |
| 30 Sep, 20 | 65 | -17.72% |
| 30 Jun, 20 | 79 | 41.07% |
| 31 Mar, 20 | 56 | -26.32% |
| 31 Dec, 19 | 76 | -6.17% |
| 30 Sep, 19 | 81 | 32.79% |
| 30 Jun, 19 | 61 | -1.61% |
| 31 Mar, 19 | 62 | -6.06% |
| 31 Dec, 18 | 66 | -22.35% |
| 30 Sep, 18 | 85 | 21.43% |
| 30 Jun, 18 | 70 | 59.09% |
| 31 Mar, 18 | 44 | -16.98% |
| 31 Dec, 17 | 53 | 8.16% |
| 30 Sep, 17 | 49 | -40.96% |
| 30 Jun, 17 | 83 | 16.90% |
| 31 Mar, 17 | 71 | 16.39% |
| 31 Dec, 16 | 61 | 45.24% |
| 30 Sep, 16 | 42 | 20.00% |
| 30 Jun, 16 | 35 | -25.53% |
| 31 Mar, 16 | 47 | -9.62% |
| 31 Dec, 15 | 52 | -22.39% |
| 30 Sep, 15 | 67 | 26.42% |
| 30 Jun, 15 | 53 | 55.88% |
| 31 Mar, 15 | 34 | 17.24% |
| 31 Dec, 14 | 29 | -6.45% |
| 30 Sep, 14 | 31 | - |
| 30 Jun, 14 | 31 | -26.19% |
| 31 Mar, 14 | 42 | - |
32 institutional shareholders have increased their position in CARA stock as of 31 Mar 24 compared to 45 in the previous quarter (a -28.89% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 30 | -9.09% |
| 31 Dec, 23 | 33 | -19.51% |
| 30 Sep, 23 | 41 | 7.89% |
| 30 Jun, 23 | 38 | -35.59% |
| 31 Mar, 23 | 59 | 37.21% |
| 31 Dec, 22 | 43 | - |
| 30 Sep, 22 | 43 | -25.86% |
| 30 Jun, 22 | 58 | -20.55% |
| 31 Mar, 22 | 73 | 35.19% |
| 31 Dec, 21 | 54 | -1.82% |
| 30 Sep, 21 | 55 | 10.00% |
| 30 Jun, 21 | 50 | 6.38% |
| 31 Mar, 21 | 47 | -6.00% |
| 31 Dec, 20 | 50 | 6.38% |
| 30 Sep, 20 | 47 | 67.86% |
| 30 Jun, 20 | 28 | -33.33% |
| 31 Mar, 20 | 42 | 2.44% |
| 31 Dec, 19 | 41 | 17.14% |
| 30 Sep, 19 | 35 | 20.69% |
| 30 Jun, 19 | 29 | -25.64% |
| 31 Mar, 19 | 39 | 2.63% |
| 31 Dec, 18 | 38 | 35.71% |
| 30 Sep, 18 | 28 | -12.50% |
| 30 Jun, 18 | 32 | -11.11% |
| 31 Mar, 18 | 36 | -2.70% |
| 31 Dec, 17 | 37 | -13.95% |
| 30 Sep, 17 | 43 | 13.16% |
| 30 Jun, 17 | 38 | 26.67% |
| 31 Mar, 17 | 30 | 25.00% |
| 31 Dec, 16 | 24 | 33.33% |
| 30 Sep, 16 | 18 | -10.00% |
| 30 Jun, 16 | 20 | -28.57% |
| 31 Mar, 16 | 28 | -6.67% |
| 31 Dec, 15 | 30 | 76.47% |
| 30 Sep, 15 | 17 | 41.67% |
| 30 Jun, 15 | 12 | 9.09% |
| 31 Mar, 15 | 11 | -38.89% |
| 31 Dec, 14 | 18 | 5.88% |
| 30 Sep, 14 | 17 | 41.67% |
| 30 Jun, 14 | 12 | - |
| 31 Mar, 14 | - | - |
30 institutional shareholders have reduced their position in CARA stock as of 31 Mar 24 compared to 33 in the previous quarter (a -9.09% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 92 | -16.36% | 21,683,438 | -10.74% | 40.04% | 2.00% | 32 | -28.89% | 30 | -9.09% |
| 31 Dec, 23 | 110 | -11.29% | 24,293,481 | -9.48% | 44.79% | 1.81% | 45 | -13.46% | 33 | -19.51% |
| 30 Sep, 23 | 124 | -10.14% | 26,837,228 | -7.87% | 49.70% | 1.70% | 52 | -24.64% | 41 | 7.89% |
| 30 Jun, 23 | 138 | -15.85% | 29,131,223 | -13.90% | 54.07% | 1.37% | 69 | 2.99% | 38 | -35.59% |
| 31 Mar, 23 | 164 | -1.20% | 33,835,514 | -0.34% | 62.81% | 1.57% | 67 | -17.28% | 59 | 37.21% |
| 31 Dec, 22 | 166 | 4.40% | 33,952,529 | -1.59% | 63.15% | 1.53% | 81 | - | 43 | - |
| 30 Sep, 22 | 159 | -10.17% | 34,502,710 | -0.68% | 64.22% | 1.53% | 81 | 6.58% | 43 | -25.86% |
| 30 Jun, 22 | 177 | -5.35% | 34,740,602 | 9.66% | 64.80% | 1.85% | 76 | 2.70% | 58 | -20.55% |
| 31 Mar, 22 | 187 | -0.53% | 31,678,911 | 5.52% | 59.21% | 1.83% | 74 | -16.85% | 73 | 35.19% |
| 31 Dec, 21 | 188 | 6.82% | 30,021,938 | 2.19% | 56.91% | 1.66% | 89 | 18.67% | 54 | -1.82% |
| 30 Sep, 21 | 176 | -4.35% | 29,378,845 | -5.28% | 58.62% | 1.53% | 75 | -21.88% | 55 | 10.00% |
| 30 Jun, 21 | 184 | 1.10% | 31,017,360 | -4.19% | 61.96% | 1.47% | 96 | 18.52% | 50 | 6.38% |
| 31 Mar, 21 | 182 | 12.35% | 32,375,292 | -0.73% | 64.86% | 1.37% | 81 | 20.90% | 47 | -6.00% |
| 31 Dec, 20 | 162 | -1.22% | 32,614,651 | -2.11% | 68.79% | 1.36% | 67 | 3.08% | 50 | 6.38% |
| 30 Sep, 20 | 164 | 7.19% | 33,319,028 | 1.87% | 71.06% | 1.45% | 65 | -17.72% | 47 | 67.86% |
| 30 Jun, 20 | 153 | 9.29% | 32,707,087 | 1.82% | 69.89% | 1.48% | 79 | 41.07% | 28 | -33.33% |
| 31 Mar, 20 | 140 | -11.95% | 32,121,301 | 2.87% | 68.75% | 1.54% | 56 | -26.32% | 42 | 2.44% |
| 31 Dec, 19 | 159 | 8.90% | 31,225,708 | 2.52% | 66.88% | 1.43% | 76 | -6.17% | 41 | 17.14% |
| 30 Sep, 19 | 146 | 8.15% | 30,457,856 | 18.84% | 68.42% | 1.65% | 81 | 32.79% | 35 | 20.69% |
| 30 Jun, 19 | 135 | -8.78% | 25,628,870 | 16.09% | 64.36% | 2.07% | 61 | -1.61% | 29 | -25.64% |
| 31 Mar, 19 | 148 | 4.96% | 22,077,470 | -7.87% | 55.82% | 1.51% | 62 | -6.06% | 39 | 2.63% |
| 31 Dec, 18 | 141 | -10.76% | 23,964,524 | 3.82% | 60.76% | 1.65% | 66 | -22.35% | 38 | 35.71% |
| 30 Sep, 18 | 158 | 11.27% | 23,082,854 | 21.84% | 60.69% | 1.88% | 85 | 21.43% | 28 | -12.50% |
| 30 Jun, 18 | 142 | 14.52% | 18,945,251 | 7.47% | 56.87% | 1.95% | 70 | 59.09% | 32 | -11.11% |
| 31 Mar, 18 | 124 | -3.13% | 17,627,964 | 4.30% | 53.94% | 2.01% | 44 | -16.98% | 36 | -2.70% |
| 31 Dec, 17 | 128 | - | 16,901,879 | -10.89% | 51.79% | 1.53% | 53 | 8.16% | 37 | -13.95% |
| 30 Sep, 17 | 128 | -18.47% | 18,967,192 | -4.79% | 58.20% | 1.52% | 49 | -40.96% | 43 | 13.16% |
| 30 Jun, 17 | 157 | 19.85% | 19,922,317 | 24.35% | 61.79% | 1.79% | 83 | 16.90% | 38 | 26.67% |
| 31 Mar, 17 | 131 | 29.70% | 16,020,762 | 16.74% | 58.68% | 2.32% | 71 | 16.39% | 30 | 25.00% |
| 31 Dec, 16 | 101 | 20.24% | 13,723,008 | 19.35% | 50.31% | 2.83% | 61 | 45.24% | 24 | 33.33% |
| 30 Sep, 16 | 84 | 23.53% | 11,498,368 | -13.57% | 42.15% | 1.77% | 42 | 20.00% | 18 | -10.00% |
| 30 Jun, 16 | 68 | -26.09% | 13,303,859 | -18.55% | 48.76% | 1.36% | 35 | -25.53% | 20 | -28.57% |
| 31 Mar, 16 | 92 | -4.17% | 16,333,717 | -19.10% | 59.92% | 1.09% | 47 | -9.62% | 28 | -6.67% |
| 31 Dec, 15 | 96 | 6.67% | 20,190,762 | 8.67% | 74.12% | 1.40% | 52 | -22.39% | 30 | 76.47% |
| 30 Sep, 15 | 90 | 21.62% | 18,579,702 | 54.59% | 72.73% | 2.62% | 67 | 26.42% | 17 | 41.67% |
| 30 Jun, 15 | 74 | 25.42% | 12,019,012 | 7.80% | 52.65% | 2.20% | 53 | 55.88% | 12 | 9.09% |
| 31 Mar, 15 | 59 | 5.36% | 11,149,420 | 7.00% | 48.88% | 2.34% | 34 | 17.24% | 11 | -38.89% |
| 31 Dec, 14 | 56 | - | 10,420,331 | 6.71% | 45.72% | 2.47% | 29 | -6.45% | 18 | 5.88% |
| 30 Sep, 14 | 56 | 14.29% | 9,764,866 | 10.98% | 42.99% | 2.84% | 31 | - | 17 | 41.67% |
| 30 Jun, 14 | 49 | 16.67% | 8,798,388 | 2.06% | 38.92% | 1.28% | 31 | -26.19% | 12 | - |
| 31 Mar, 14 | 42 | - | 8,621,122 | - | 55.07% | - | 42 | - | - | - |
Cara Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Cara Therapeutics's stock was made by Posner Christopher on May 06 2024, selling 3,936 shares at $0.75 per share (valued at $2.95K).
Cara Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | 1 | - |
| Q3 2023 | 1 | 1 | 100.00% |
| Q2 2023 | 10 | 7 | 142.86% |
| Q1 2023 | 5 | 7 | 71.43% |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | 5 | 12 | 41.67% |
| Q1 2022 | 12 | 5 | 240.00% |
| Q4 2021 | 7 | 3 | 233.33% |
| Q3 2021 | 5 | 6 | 83.33% |
| Q2 2021 | 10 | 4 | 250.00% |
| Q1 2021 | 16 | 11 | 145.45% |
| Q4 2020 | 6 | 15 | 40.00% |
| Q3 2020 | - | 3 | - |
| Q2 2020 | 16 | 16 | 100.00% |
| Q1 2020 | 12 | 7 | 171.43% |
| Q4 2019 | 6 | 23 | 26.09% |
| Q3 2019 | 4 | 14 | 28.57% |
| Q2 2019 | 13 | 4 | 325.00% |
| Q1 2019 | 5 | 10 | 50.00% |
0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Cara Therapeutics's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | - | 1 | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | 7 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 5 | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | 5 | - |
| Q4 2021 | - | 3 | - |
| Q3 2021 | - | 6 | - |
| Q2 2021 | - | 4 | - |
| Q1 2021 | - | 11 | - |
| Q4 2020 | - | 15 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 13 | - |
| Q1 2020 | - | 4 | - |
| Q4 2019 | - | 13 | - |
| Q3 2019 | - | 10 | - |
| Q2 2019 | - | 4 | - |
| Q1 2019 | - | 9 | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 1 open market sell trades of Cara Therapeutics's stocks.
CARA Ownership FAQ
Who Owns Cara Therapeutics?
Cara Therapeutics is owned by institutional shareholders (40.04%), insiders (15.25%), and public (44.70%). The largest institutional shareholder of Cara Therapeutics is BLACKROCK INC. (6.32% of total shares) and the top mutual fund owner is Federated Hermes MDT Series (0.32% of total shares).
Who are the major institutional shareholders of Cara Therapeutics?
Cara Therapeutics's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, DISCIPLINED GROWTH INVESTORS INC /MN, CHESCAPMANAGER LLC, and FARALLON CAPITAL MANAGEMENT LLC. The top five shareholders own together 20.27% of the company's share outstanding.
How many Cara Therapeutics shareholders are there?
As of Mar 2024, there are 92 institutional shareholders of Cara Therapeutics.
What percentage of Cara Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC owns 3.42M shares of Cara Therapeutics, representing 6.32% of the company's total shares outstanding, valued at $3.11M (as of Mar 2024).
What percentage of Cara Therapeutics is owned by VANGUARD GROUP INC?
As of Mar 2024, VANGUARD GROUP INC holds 2.48M shares of Cara Therapeutics (CARA), compromising 4.58% of the company, valued at $2.26M.
What percentage of Cara Therapeutics is owned by DISCIPLINED GROWTH INVESTORS INC /MN?
DISCIPLINED GROWTH INVESTORS INC /MN is the third largest holder of Cara Therapeutics. The company owns 1.82M of the company's shares outstanding (worth $1.65M).